Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.

Brunani, A; Caumo, A; Graci, S; Castagna, G; Viberti, G; Liuzzi, A

Brunani, A; Caumo, A; Graci, S; Castagna, G; Viberti, G; Liuzzi, A.

Affiliation

Brunani A; Department of Internal Medicine, Ospedale San Giuseppe, IRCCS, Istituto Auxologico Italiano, Verbania, Italy. brunani@auxologico.it

Diabetes Obes Metab ; 10(6): 460-7, 2008 Jun.

Article in En | MEDLINE | ID: mdl-17394563

Subject(s)

Hyperinsulinism/drug therapy; Hypoglycemic Agents/pharmacology; Metformin/pharmacology; Obesity/drug therapy; Thiazolidinediones/pharmacology; Adipose Tissue/drug effects; Adolescent; Adult; Aged; B-Lymphocytes/drug effects; Blood Glucose/drug effects; Blood Glucose/metabolism; Body Composition/drug effects; Female; Humans; Hypoglycemic Agents/therapeutic use; Insulin Resistance; Lipid Metabolism/drug effects; Male; Metformin/therapeutic use; Middle Aged; Obesity/diet therapy; Obesity, Morbid/diet therapy; Obesity, Morbid/drug therapy; Rosiglitazone; Thiazolidinediones/therapeutic use; Weight Loss/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazolidinediones / Hyperinsulinism / Hypoglycemic Agents / Metformin / Obesity Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2008 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links